Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2005
05/19/2005WO2005044292A2 Biomarkers of resistance to hiv-infections in humans and biological applications thereof
05/19/2005WO2005044269A1 Cytokine inhibitory drugs for treatment of macular degeneration
05/19/2005WO2005044259A1 Composition and method for treating macular degeneration
05/19/2005WO2005044200A2 Methods and compositions for treating mcp-1 related pathologies
05/19/2005WO2005044197A2 Synthesis of glycopeptides with superior pharmacokinetic properties
05/19/2005WO2005044196A2 Novel modulators of amyloid-beta production and uses thereof
05/19/2005WO2005044192A2 Triazole compounds and uses related thereto
05/19/2005WO2005044188A2 Compositions and methods to modulate an immune response to an immunogenic therapeutic agent
05/19/2005WO2005044142A2 Intravascular devices and fibrosis-inducing agents
05/19/2005WO2005032511A3 Nanoparticulate therapeutic biologically active agents
05/19/2005WO2005027978A3 Albumin-binding derivatives of therapeutic peptides
05/19/2005WO2005025517A9 Animal model for protease activity and liver damage
05/19/2005WO2005025501A3 Co-administration of polysaccharide with a chemotherapeutic agent for the treatment of cancer
05/19/2005WO2005023288A8 Treatment of fibrotic disease
05/19/2005WO2005022160A3 Diagnosis and treatment of micobacterial infections
05/19/2005WO2005021575A3 Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties
05/19/2005WO2005020898A8 Methods of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i)
05/19/2005WO2005020879A3 Compositions for treating pathologies that necessitate suppression of gastric acid secretion
05/19/2005WO2005018542A3 Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
05/19/2005WO2005017093A8 Polypeptides of streptococcus pyogenes
05/19/2005WO2005007079A3 Inactivators and bivalent inhibitors of glyoxalase i and methods of inhibiting tumor growth
05/19/2005WO2005003350A8 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER’S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/19/2005WO2005002617A3 Use of compositions comprising a soluble form of hla-g in the treatment of blood diseases
05/19/2005WO2004111075A8 Alternative reading frame polypeptides for treatment
05/19/2005WO2004100997A3 Spacer moiety for poly(ethylene glycol) -modified peptides
05/19/2005WO2004100979A3 Liquid stabilized protein formulations in coated pharmaceutical containers
05/19/2005WO2004099246A3 Peptides for use in treating obesity
05/19/2005WO2004099232A3 Selective r-cadherin antagonists and methods
05/19/2005WO2004094590A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
05/19/2005WO2004094452A3 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
05/19/2005WO2004093894A8 Use of b7-h3 as an immunoregulatory agent
05/19/2005WO2004087743A3 Anti-hypertensive peptide derivatives and process for preparation thereof
05/19/2005WO2004087063A3 Use of erythropoietin in stroke recovery
05/19/2005WO2004078145B1 Combination therapy with glatiramer acetate and simvastatin for the treatment of multiple sclerosis
05/19/2005WO2004076639B1 Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
05/19/2005WO2004076634A3 Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
05/19/2005WO2004074448A3 mTOR KINASE-ASSOCIATED PROTEINS
05/19/2005WO2004069201A3 Compounds useful in coating stents to prevent and treat stenosis and restenosis
05/19/2005WO2004052292A3 Histone deacetylase inhibitor enhancement of trail-induced apoptosis
05/19/2005WO2004039244A3 Methods and kits for diagnosing tumorigenicity
05/19/2005WO2004024868A3 Product and process for liquefaction of mucus or sputum
05/19/2005WO2004022762A9 Orthopoxvirus vectors, genes and products thereof
05/19/2005WO2004016764A3 eNOS MUTANTS USEFUL FOR GENE THERAPY
05/19/2005WO2004016726A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
05/19/2005WO2004016224A3 Antisense modulation of vegf co-regulated chemokine-1 expression
05/19/2005WO2004015125A9 Process for preparing peptides with anti-hypertensive properties
05/19/2005WO2003105767A8 Antifungal parenteral products
05/19/2005WO2003092592A3 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
05/19/2005WO2003066805A3 Antisense modulation of complement component c3 expression
05/19/2005WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
05/19/2005WO2003012035A3 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
05/19/2005WO2002034934A3 Stresscopins and their uses
05/19/2005US20050108782 Transgenic RS1-/- animal and uses thereof
05/19/2005US20050107601 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders
05/19/2005US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection
05/19/2005US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases
05/19/2005US20050107585 Signal-1/signal-2 bifunctional peptide inhibitors
05/19/2005US20050107584 Synthetic peptides and kits for diagnosis of anti-phospholipid syndrome
05/19/2005US20050107581 Steam stripping beads under vacuum; divinyl benzene/ethyl vinyl benzene copolymers; dilution; for production of cephalosporin C and insulin
05/19/2005US20050107543 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates
05/19/2005US20050107452 Black soybean polysaccharides
05/19/2005US20050107441 screening for drugs that alter glucose production by modulating gene expression and/or activity of the nuclear receptor short heterodimer partners, then using the drugs as hypoglycemic or hyperglycemic agents; antidiabetic agents; metabolic disorders
05/19/2005US20050107392 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate
05/19/2005US20050107363 administering to mammals drugs such as 5,10-dihydro-4,6,8-trihydroxy-10-(3,7,11-trimethyl-trans-2,trans-6,10-dodecatrienyl)-11H-dibenzo[b,e][1,4]diazepin-11-one, as anticarcinogenic agents
05/19/2005US20050107328 Antisense modulation of polo-like kinase expression
05/19/2005US20050107327 Administration of an NPY receptor antagonist to decrease the expression of the NPY gene; control cholesterol, LDL cholesterol and triglyserides in blood, prevent development of atherosclerosis
05/19/2005US20050107326 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells
05/19/2005US20050107323 Cardiac arrhythmia treatment methods
05/19/2005US20050107321 FLK-1 is a receptor for vascular endothelial growth factor
05/19/2005US20050107320 Improve phenotypic response and receptive to the therapeutic agent by administering a vector comprising a gene into a mammalian cell, wherein expression of the heterologous protein within the cell; brian neurological disorder, Parkinson's disease; tissue-targeted therapy
05/19/2005US20050107319 Method of inhibiting factor B-mediated complement activation, and the uses thereof
05/19/2005US20050107317 Nucleic acid molecule of the short-chain dehydrogenase gene family, an antibody, an aptamer or receptors, polypeptide encoded thereby; biodrug for treatment of metabolism of triglycerides, metabolic disorders as obesity, eating disorder, cachexia, diabetes mellitus, hypertension, heart disease
05/19/2005US20050107315 Mammary-associated serum amuloid a3 promoter sequences and used for same
05/19/2005US20050107314 Modulation of cd200 receptors
05/19/2005US20050107309 Lowering elevated post-prandial blood glucose levels by increasing incretin half-life comprising administering inhibitor of Dipeptidyl Peptidase (DP IV) or enzymes having DP-IV-like activity; insulinotropic effects are enhanced
05/19/2005US20050107302 Applying formulation containing ovalbumin containing a growth factor selected from epidermal growth factor, transforming growth factor alpha, fibroblast growth factors, phenoxyethanol, triethanolamine, carbomer for scar prevention
05/19/2005US20050107301 administering to a mammal an effective amount of an anti-thrombin protein from the salivary glands of the species, low toxicity, little or no antigenicity, short clearance time from circulation
05/19/2005US20050107300 administering erythrocyte, granulocyte and/or platelet cell growth factors, for therapy of blood disorders
05/19/2005US20050107297 Novel poly(ethylene glycol) modified compounds and uses thereof
05/19/2005US20050107296 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/19/2005US20050107294 in an injectable form and to be administered through infiltrations inside and around cutaneous chronic ischemic ulcerative wounds as to prevent diabetic limb amputation
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050107292 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
05/19/2005US20050107290 Histone deactylase as enzyme inhibitor; anticancer agents
05/19/2005US20050107289 Anti-microbial peptides and compositions
05/19/2005US20050107288 e.g. (S)-2-(3,5-Difluorophenyl)-1-((3S,7S,13S,16S,19S)-13,16,17-trimethyl-2,6,12,15,18-pentaoxo-5-oxa-1,11,14,17-tetraaza-tricyclo[17.3.0.07,11]docos-3-ylcarbamoyl)-ethylammonium 2,2,2-trifluoroacetate
05/19/2005US20050107287 Administering cisplatin; drug delivery; reduced dosage to prevent release into systemic circulation; platinum containing compound entrapped in salt crystals; andone or more lipids
05/19/2005US20050107285 comprising an agent which inhibits Fc gamma RIIIb receptor activity, activation or expression; Rheumatoid Arthritis
05/19/2005US20050107277 Polyalkylene polymer compounds and uses thereof
05/19/2005US20050107256 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
05/19/2005US20050106731 siRNA-mediated gene silencing with viral vectors
05/19/2005US20050106726 RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
05/19/2005US20050106698 Recombinant kid pregastric esterase and methods for its production and use
05/19/2005US20050106697 Expression vector comprising nucleotide sequences coding transferases associated with glyceride formation for use in treating obesity and enhancing food quality
05/19/2005US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
05/19/2005US20050106691 Process for the production of ramoplanin-like amide derivatives
05/19/2005US20050106679 Leptin proteins
05/19/2005US20050106678 Human circulating cytokine CC-1
05/19/2005US20050106676 Novel proteins having hemolytic activity and genes encoding the protein
05/19/2005US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders
1 ... 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 ... 3163